12-AMINO-9-ETHYL-6,7,8,11-TETRAHYDRO-7,11-METHANO-CYCLOOCTA-[B]-QUINOLINE
Compound with spectra: 1 NMR
![12-AMINO-9-ETHYL-6,7,8,11-TETRAHYDRO-7,11-METHANO-CYCLOOCTA-[B]-QUINOLINE](/api/compound/AInNPJAY1ZI.png?ph=true&h=300&w=458 "12-AMINO-9-ETHYL-6,7,8,11-TETRAHYDRO-7,11-METHANO-CYCLOOCTA-[B]-QUINOLINE")
| SpectraBase Compound ID | AInNPJAY1ZI |
|---|---|
| InChI | InChI=1S/C18H20N2/c1-2-11-7-12-9-13(8-11)17-16(10-12)20-15-6-4-3-5-14(15)18(17)19/h3-6,8,12-13H,2,7,9-10H2,1H3,(H2,19,20)/t12-,13+/m0/s1 |
| InChIKey | JTXWLCKLIIRZKL-QWHCGFSZSA-N |
| Mol Weight | 264.37 g/mol |
| Molecular Formula | C18H20N2 |
| Exact Mass | 264.162649 g/mol |
| Enantiomer InChIKey | JTXWLCKLIIRZKL-OLZOCXBDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
12-AMINO-6,7,8,11-TETRAHYDRO-9-METHYL-7,11-METHANO-CYCLOOCTA-[B]-QUINOLINE
12-CHLORO-9-METHYL-6,7,10,11-TETRAHYDRO-7,11-METHANO-CYCLOOCTA-[B]-QUINOLINE
9-[(4-Chlorobenzyl)amino]-3,3-dimethyl-1,2,3,4-tetrahydro-1-acridinol
N,N-[1',2',3',4'-Tetrahydroacrydin-9'-yl]-N-[8"-(1"',2''',3''',4''-tetrahydroacridin-9'"-yl)oct-7"-en-1"-yl]-amine
1(2H)-acridinone, 9-amino-3,4-dihydro-3,3,5,7-tetramethyl-
3-Methylene-2,3,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-4-one
rel-(6R,12bR)-6-methyl-2,3,6,7,12,12b-hexahydro-1H-[1,2]oxazino[2',3':1,2]pyrido[3,4-b]indole
2,3,4,9-tetrahydro-1-(trifluoromethyl)-1H-pyrido[3,4-b]indole-2-carboxanilide
AFFKZFRPDOXBJM-XIKOKIGWSA-N
[(1R,12bS)-1-ethyl-3,4,6,7,12,12b-hexahydro-2H-indolo[2,3-a]quinolizin-1-yl]methanol
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis, in Vitro Pharmacology, and Molecular Modeling of syn-Huprines as Acetylcholinesterase Inhibitors | Journal of Medicinal Chemistry | 2001 |